Pratirakshak Immuno-Biological Processes Products Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-05-2024
- Paid Up Capital ₹ 0.10 M
as on 28-05-2024
- Company Age 43 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 82.09%
(FY 2017)
- Profit 7.19%
(FY 2017)
- Ebitda -138.83%
(FY 2017)
- Net Worth 1.97%
(FY 2017)
- Total Assets 0.41%
(FY 2017)
About Pratirakshak Immuno-Biological Processes Products
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gursaran Talwar and Raksha Talwar serve as directors at the Company.
- CIN/LLPIN
U24232DL1981PTC012622
- Company No.
012622
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pratirakshak Immuno-Biological Processes Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gursaran Talwar  | Director | 20-Nov-1981 | Current |
| Raksha Talwar | Director | 12-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Pratirakshak Immuno-Biological Processes Products.
Pratirakshak Immuno-Biological Processes Products Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 82.09% increase. The company also saw a slight improvement in profitability, with a 7.19% increase in profit. The company's net worth moved up by a moderate rise of 1.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pratirakshak Immuno-Biological Processes Products?
In 2017, Pratirakshak Immuno-Biological Processes Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pratirakshak Immuno-Biological Processes Products?
Unlock and access historical data on people associated with Pratirakshak Immuno-Biological Processes Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pratirakshak Immuno-Biological Processes Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pratirakshak Immuno-Biological Processes Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
